Jim Gilligan, PhD, MBIS

home / authors / jim-gilligan-phd-mbis

Dr Gilligan is the chief science officer and interim CEO of Tryp Therapeutics.

Articles

The Gut-Brain Connection: An Upcoming Study on Psilocybin-Assisted Psychotherapy and Irritable Bowel Syndrome

August 14th 2023

A phase 2A trial recently received confirmation to proceed in investigating psilocybin-assisted psychotherapy in the treatment of adult patients with IBS.

Psychedelics for the Treatment of Binge Eating Disorder in Males

Leah Kuntz;Jim Gilligan, PhD, MBIS

August 29th 2022

This new study is evaluating how effective psychedelics can be in the treatment of binge eating disorder.

Latest Updated Articles

Published: March 19th 2021 | Updated: May 1st 2025

Mini Quiz: Treatment for Pedophilia?

Published: January 23rd 2017 | Updated: May 1st 2025

Mini Quiz: Characterizing Sexual Deviation

Published: April 1st 2019 | Updated: May 1st 2025

Mini Quiz: Assessment of Malingering

Published: August 3rd 2015 | Updated: May 1st 2025

Mini Quiz: DSM-5 Basics

Published: May 14th 2024 | Updated: May 1st 2025

DBS: A Solution to Treatment-Resistant Schizophrenia

Published: March 23rd 2021 | Updated: May 1st 2025

Poor DSM-5—So Misunderstood!

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777